{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:39:18Z","timestamp":1790476758237,"version":"4.1.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019042","name":"Jiangsu Ocean University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81602971"],"award-info":[{"award-number":["81602971"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010014","name":"Six Talent Peaks Project in Jiangsu Province","doi-asserted-by":"publisher","award":["2019-SWYY-128"],"award-info":[{"award-number":["2019-SWYY-128"]}],"id":[{"id":"10.13039\/501100010014","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ejmech.2021.113879","type":"journal-article","created":{"date-parts":[[2021,10,4]],"date-time":"2021-10-04T15:26:29Z","timestamp":1633361189000},"page":"113879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Optimization of bifunctional piperidinamide derivatives as \u03c31R Antagonists\/MOR agonists for treating neuropathic pain"],"prefix":"10.1016","volume":"226","author":[{"given":"Jiaying","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yurong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guisen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113879_bib1","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1016\/j.pain.2011.06.017","article-title":"A\u00a0new definition of neuropathic pain","volume":"152","author":"Jensen","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.113879_bib2","first-page":"S263","article-title":"Consequences of neuropathic pain: quality-of-life issues and associated costs","volume":"12","author":"Mccarberg","year":"2006","journal-title":"Am. J. Manag. Care"},{"key":"10.1016\/j.ejmech.2021.113879_bib3","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00019053-200927020-00002","article-title":"Neuropathic pain: quality-of-life impact, costs and cost effectiveness of therapy","volume":"27","author":"O'Connor","year":"2009","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.ejmech.2021.113879_bib4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: a systematic review of epidemiological studies","volume":"155","author":"Van Hecke","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.113879_bib5","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.pain.2013.06.004","article-title":"Interventional management of neuropathic pain: NeuPSIG recommendations","volume":"154","author":"Dworkin","year":"2013","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.113879_bib6","first-page":"844","article-title":"Pharmacologic management of chronic neuropathic pain: review of the Canadian Pain Society consensus statement","volume":"63","author":"Mu","year":"2017","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.ejmech.2021.113879_bib7","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejmech.2021.113879_bib8","first-page":"171","article-title":"History of opium poppy and morphine","volume":"33","author":"Norn","year":"2005","journal-title":"Dan. Medicinhist. Arbog"},{"key":"10.1016\/j.ejmech.2021.113879_bib9","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1097\/ALN.0b013e318238bba6","article-title":"Molecular mechanisms of opioid receptor-dependent signaling and behavior","volume":"115","author":"Al-Hasani","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.ejmech.2021.113879_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.aat.2010.12.008","article-title":"Mu opioid receptors in pain management","volume":"49","author":"Pasternak","year":"2011","journal-title":"Acta Anaesthesiol. Taiwanica"},{"key":"10.1016\/j.ejmech.2021.113879_bib11","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.mayocp.2015.04.010","article-title":"Opioid analgesics, mayo","volume":"90","author":"Jamison","year":"2015","journal-title":"Clin. Proc."},{"key":"10.1016\/j.ejmech.2021.113879_bib12","first-page":"870","article-title":"Opioid therapy and its side effects: a review","volume":"19","author":"Khademi","year":"2016","journal-title":"Arch. Iran. Med."},{"key":"10.1016\/j.ejmech.2021.113879_bib13","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.4155\/fmc.14.54","article-title":"Selective sigma-1 receptor antagonists for the treatment of pain","volume":"6","author":"Almansa","year":"2014","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2005.01.036","article-title":"Formalin-induced pain is reduced in sigma-1 receptor knockout mice","volume":"511","author":"Cend\u00e1n","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113879_bib15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s00213-009-1513-8","article-title":"Antagonism by haloperidol and its metabolites of mechanical hypersensitivity induced by intraplantar capsaicin in mice: role of sigma-1 receptors","volume":"205","author":"Entrena","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2021.113879_bib16","doi-asserted-by":"crossref","first-page":"8211","DOI":"10.1021\/jm3007323","article-title":"Synthesis and biological evaluation of the 1-arylpyrazole class of sigma-1 receptor antagonists: identification of 4-{2-[5-methyl-1-(naphthalen-2-yl)-1H-pyrazol-3-yloxy]ethyl}morpholine (S1RA, E-52862)","volume":"55","author":"Diaz","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib17","doi-asserted-by":"crossref","first-page":"10404","DOI":"10.1021\/jm501207r","article-title":"Synthesis and biological evaluation of novel sigma-1 receptor antagonists based on pyrimidine scaffold as agents for treating neuropathic pain","volume":"57","author":"Lan","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib18","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1021\/acs.jmedchem.5b01416","article-title":"Synthesis and biological evaluation of novel sigma-1 receptor ligands for treating neuropathic pain: 6-hydroxypyridazinones","volume":"59","author":"Cao","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib19","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1021\/jm501920g","article-title":"Synthesis and structure-activity relationship (SAR) study of a new series of selective sigma-1 receptor ligands for the treatment of pain: 4-aminotriazoles","volume":"58","author":"D\u00edaz","year":"2015","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib20","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/ars.2014.5993","article-title":"The sigma-1 receptor engages the redox-regulated HINT1 protein to bring opioid analgesia under NMDA receptor negative control","volume":"22","author":"Rodriguez-Munoz","year":"2015","journal-title":"Antioxidants Redox Signal."},{"key":"10.1016\/j.ejmech.2021.113879_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cell.2012.12.004","article-title":"Dynamic interaction between sigma-1 receptor and Kv1.2 shapes neuronal and behavioral responses to cocaine","volume":"152","author":"Kourrich","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.ejmech.2021.113879_bib22","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1167\/iovs.08-1867","article-title":"Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction","volume":"49","author":"Tchedre","year":"2008","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.ejmech.2021.113879_bib23","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/S0022-3565(25)24045-9","article-title":"Selective antagonism of opioid analgesia by a sigma system","volume":"271","author":"Chien","year":"1995","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113879_bib24","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0304-3940(95)11504-P","article-title":"Sigma antagonists potentiate opioid analgesia in rats","volume":"190","author":"Chien","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmech.2021.113879_bib25","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1124\/jpet.113.208272","article-title":"Modulation of peripheral mu-opioid analgesia by sigma-1 receptors","volume":"348","author":"Sanchez-Fernandez","year":"2013","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113879_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ejphar.2013.04.018","article-title":"Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects","volume":"711","author":"Vidal-Torres","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113879_bib27","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.neuropharm.2013.03.002","article-title":"Potentiation of morphine-induced mechanical antinociception by sigma-1 receptor inhibition: role of peripheral sigma-1 receptors","volume":"70","author":"Sanchez-Fernandez","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2021.113879_bib28","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1021\/jm00093a014","article-title":"Enantiomeric N-substituted N-normetazocines: a comparative study of affinities at sigma, PCP, and mu opioid receptors","volume":"35","author":"Carroll","year":"1992","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib29","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1021\/jo01092a012","article-title":"Structures related to morphine. XII.1 (\u00b1)-2\u2032Hydroxy5,9-dimethyl-2-phenethyl-6,7-benzomorphan (NIH 7519) and its optical forms","volume":"24","author":"May","year":"1959","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib30","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1021\/jo01084a655","article-title":"Communications- a new potent synthetic analgesic","volume":"24","author":"May","year":"2003","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib31","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.ejmech.2016.09.077","article-title":"(+)-and (-)-Phenazocine enantiomers: evaluation of their dual opioid agonist\/sigma-1 antagonist properties and antinociceptive effects","volume":"125","author":"Prezzavento","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib32","doi-asserted-by":"crossref","first-page":"2434","DOI":"10.1021\/acs.jmedchem.9b01256","article-title":"4-aryl-1-oxa-4,9-diazaspiro[5.5]undecane derivatives as dual mu-opioid receptor agonists and sigma-1 receptor antagonists for the treatment of pain","volume":"63","author":"Garc\u00eda","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib33","doi-asserted-by":"crossref","first-page":"15508","DOI":"10.1021\/acs.jmedchem.0c01127","article-title":"Discovery of EST73502, a dual mu-opioid receptor agonist and sigma-1 receptor antagonist clinical candidate for the treatment of Pain","volume":"63","author":"Garc\u00eda","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib34","doi-asserted-by":"crossref","first-page":"113658","DOI":"10.1016\/j.ejmech.2021.113658","article-title":"Bifunctional \u03bc opioid and \u03c31 receptor ligands as novel analgesics with reduced side effects","volume":"223","author":"Zhuang","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib35","doi-asserted-by":"crossref","first-page":"112144","DOI":"10.1016\/j.ejmech.2020.112144","article-title":"Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain","volume":"191","author":"Xiong","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib36","doi-asserted-by":"crossref","first-page":"8895","DOI":"10.1021\/acs.jmedchem.8b01136","article-title":"Optimization of a series of mu opioid receptor agonists with high G protein signaling bias","volume":"61","author":"Kennedy","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib37","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1021\/jm00256a003","article-title":"Synthetic analgesics. Synthesis and pharmacology of the diastereoisomers of N-(3-methyl-1-(2-phenylethyl)-4-piperidyl)-N-phenylpropanamide and N-(3-methyl-1-(1-methyl-2-phenylethyl)-4-piperidyl)-N-phenylpropanamide","volume":"17","author":"Van Bever","year":"1974","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib38","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1021\/ml200117z","article-title":"Metabolism of 4-aminopiperidine drugs by cytochrome P450s: molecular and quantum mechanical insights into drug design","volume":"2","author":"Sun","year":"2011","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113879_bib39","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1039\/C9MD00222G","article-title":"Affinity of fentanyl and its derivatives for the sigma-1 receptor","volume":"10","author":"Lipinski","year":"2019","journal-title":"Med. Chem. Comm."},{"key":"10.1016\/j.ejmech.2021.113879_bib40","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1021\/jm049433t","article-title":"Synthesis and structure-activity relationships of 1-aralkyl-4-benzylpiperidine and 1-aralkyl-4-benzylpiperazine derivatives as potent sigma ligands","volume":"48","author":"Costantino","year":"2005","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib41","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","article-title":"Structure of the micro-opioid receptor-Gi protein complex","volume":"558","author":"Koehl","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113879_bib42","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/syn.20103","article-title":"Phenytoin differentially modulates the affinity of agonist and antagonist ligands for sigma-1 receptors of Guinea pig brain","volume":"55","author":"Cobos","year":"2005","journal-title":"Synapse"},{"key":"10.1016\/j.ejmech.2021.113879_bib43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1042\/bse0590043","article-title":"Biological membranes","volume":"59","author":"Watson","year":"2015","journal-title":"Essays Biochem."},{"key":"10.1016\/j.ejmech.2021.113879_bib44","first-page":"412","article-title":"Acetic acid for analgesic screening, Fed","volume":"18","author":"Koster","year":"1959","journal-title":"SAVE Proc."},{"key":"10.1016\/j.ejmech.2021.113879_bib45","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3959(94)00095-V","article-title":"The formalin test: scoring properties of the first and second phases of the pain response in rats","volume":"60","author":"Abbott","year":"1995","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.113879_bib46","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.ejmech.2014.04.019","article-title":"Synthesis and biological evaluation of a novel sigma-1 receptor antagonist based on 3,4-dihydro-2(1H)-quinolinone scaffold as a potential analgesic","volume":"79","author":"Lan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib47","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0022-3565(25)05180-8","article-title":"Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines","volume":"107","author":"Eddy","year":"1953","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2021.113879_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.pharep.2014.08.013","article-title":"The antinociceptive effect and mechanisms of action of pregabalin in mice","volume":"67","author":"Kaygisiz","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2021.113879_bib49","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0304-3959(88)90209-6","article-title":"A\u00a0peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man","volume":"33","author":"Bennett","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.113879_bib50","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/0304-3959(88)90026-7","article-title":"A\u00a0new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia","volume":"32","author":"Hargreaves","year":"1988","journal-title":"Pain"},{"key":"10.1016\/j.ejmech.2021.113879_bib51","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1467-2995.2006.00337.x","article-title":"Comparison of opioid receptor binding in horse, Guinea pig, and rat cerebral cortex and cerebellum","volume":"34","author":"Thomasy","year":"2007","journal-title":"Vet. Anaesth. Analg."},{"key":"10.1016\/j.ejmech.2021.113879_bib52","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1021\/jm400408r","article-title":"Synthesis and biological investigation of coumarin piperazine (piperidine) derivatives as potential multireceptor atypical antipsychotics","volume":"56","author":"Chen","year":"2013","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib53","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/0922-4106(92)90153-M","article-title":"Characterization of the binding of [3H] (+)-pentazocine to sigma recognition sites in Guinea pig brain","volume":"227","author":"Dehaven-Hudkins","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113879_bib54","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1476-5381.1980.tb10422.x","article-title":"Effects of changes in the structure of enkephalins and of narcotic analgesic drugs on their interactions with mu- and delta-receptors","volume":"68","author":"Kosterlitz","year":"1980","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113879_bib55","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","article-title":"Structure of the micro-opioid receptor-Gi protein complex","volume":"558","author":"Koehl","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2021.113879_bib56","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1021\/acs.jmedchem.8b01327","article-title":"Synthesis, biological, and structural explorations of new zwitterionic derivatives of 14- O-methyloxymorphone, as potent mu\/delta opioid agonists and peripherally selective antinociceptives","volume":"62","author":"Spetea","year":"2019","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s00213-005-0127-z","article-title":"Antinociceptive effects of haloperidol and its metabolites in the formalin test in mice","volume":"182","author":"Cend\u00e1n","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.ejmech.2021.113879_bib58","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S1734-1140(12)70853-8","article-title":"Pregabalin antinociception and its interaction with tramadol in acute model of pain","volume":"64","author":"Meymandi","year":"2012","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2021.113879_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J.\u00a0Neurosci. Methods"},{"key":"10.1016\/j.ejmech.2021.113879_bib60","doi-asserted-by":"crossref","first-page":"173638","DOI":"10.1016\/j.ejphar.2020.173638","article-title":"Acute and chronic bupropion treatment does not prevent morphine-induced conditioned place preference in mice","volume":"889","author":"McKendrick","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2021.113879_bib61","doi-asserted-by":"crossref","first-page":"15709","DOI":"10.1021\/acs.jmedchem.0c01367","article-title":"Synthesis and biological characterization of cyclic disulfide-containing peptide analogs of the multifunctional opioid\/neuropeptide FF receptor agonists that produce long-lasting and nontolerant antinociception","volume":"63","author":"Zhang","year":"2020","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113879_bib62","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature19112","article-title":"Structure-based discovery of opioid analgesics with reduced side effects","volume":"537","author":"Manglik","year":"2016","journal-title":"Nature"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:38:12Z","timestamp":1759329492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421007285"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":62,"alternative-id":["S0223523421007285"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113879","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of bifunctional piperidinamide derivatives as \u03c31R Antagonists\/MOR agonists for treating neuropathic pain","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113879"}}